Company Filing History:
1 out of 5 
1 out of 9,166 
Years Active: 2010-2018
Title: Kuei-Tai Lai: Innovator in Antibody and Anticancer Research
Introduction
Kuei-Tai Lai is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the fields of biotechnology and pharmaceuticals, particularly in the development of novel antibodies and anticancer agents. With a total of 2 patents, his work has the potential to impact public health and cancer treatment.
Latest Patents
One of Kuei-Tai Lai's latest patents focuses on H1N1 flu virus neutralizing antibodies. This invention includes an antibody or a binding fragment of the antibody against the H1N1 virus, featuring a heavy chain variable region and a light chain variable region. The heavy chain variable region contains complementarity determining regions (CDR) with specific amino acid sequences, while the light chain variable region also contains CDRs with distinct sequences. This invention outlines a method for treating or preventing H1N1 infection by administering the antibody to a subject.
Another significant patent involves azulene-oxindole compounds as multiple-kinase inhibitors, which are useful as anticancer agents. This invention describes novel azulene-oxindole compounds that potentially inhibit multiple kinases, making them applicable in treating diseases such as cancer or inflammatory conditions.
Career Highlights
Kuei-Tai Lai has worked with notable organizations, including Medigen Biotechnology Corporation and the Industrial Technology Research Institute. His experience in these institutions has allowed him to advance his research and contribute to innovative solutions in biotechnology.
Collaborations
Throughout his career, Kuei-Tai Lai has collaborated with esteemed colleagues, including Young-Sun Lin and Huei-Luen Huang. These partnerships have fostered a collaborative environment that enhances the development of groundbreaking inventions.
Conclusion
Kuei-Tai Lai's contributions to the fields of antibody research and anticancer agents highlight his innovative spirit and dedication to improving health outcomes. His patents reflect a commitment to addressing significant medical challenges, making him a noteworthy figure in the biotechnology landscape.